Multimodal treatment of metastatic colorectal cancer.
Metastases to the liver is the leading cause of death in patients with colorectal cancer. The authors review the data on diagnosis and management of this clinical problem, and they discuss management options that can be considered. Complete surgical resection of metastases from colorectal cancer that are localized to the liver results in 5-year survival rates ranging from 26% to 40%. By adding modalities such as targeted systemic therapy and other "local" treatments for liver metastases, further gains in survival are anticipated.